Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (111-120 of 192) with videos related to

Pageof 20
Sort By:
British Journal of Clinical Pharmacology|July 11, 2006
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjectsTeijo I Saari, Kari Laine, Kari Leino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2019
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In HumansMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Cyclosporine markedly raises the plasma concentrations of repaglinideLauri I Kajosaari, Mikko Niemi, Mikko Neuvonen, et al.
Journal of Clinical Psychopharmacology|June 15, 2013
A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophreniaKatarina Meskanen, Heidi Ekelund, Jarmo Laitinen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2016
Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate PioglitazoneMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate SimvastatinMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 10, 2018
Semimechanistic Population Pharmacokinetic Model to Predict the Drug-Drug Interaction Between S-ketamine and Ticlopidine in Healthy Human VolunteersMuhammad W Ashraf, Marko A Peltoniemi, Klaus T Olkkola, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-lifeTeijo I Saari, Kari Laine, Kari Leino, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypesMikko Niemi, Ingolf Cascorbi, Ramona Timm, et al.
European Journal of Clinical Pharmacology|June 8, 2006
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamideMikko Niemi, Aleksi Tornio, Marja K Pasanen, et al.
Pageof 20

Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
British Journal of Clinical Pharmacology|July 11, 2006
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjectsTeijo I Saari, Kari Laine, Kari Leino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2019
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In HumansMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Cyclosporine markedly raises the plasma concentrations of repaglinideLauri I Kajosaari, Mikko Niemi, Mikko Neuvonen, et al.
Journal of Clinical Psychopharmacology|June 15, 2013
A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophreniaKatarina Meskanen, Heidi Ekelund, Jarmo Laitinen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2016
Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate PioglitazoneMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate SimvastatinMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 10, 2018
Semimechanistic Population Pharmacokinetic Model to Predict the Drug-Drug Interaction Between S-ketamine and Ticlopidine in Healthy Human VolunteersMuhammad W Ashraf, Marko A Peltoniemi, Klaus T Olkkola, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-lifeTeijo I Saari, Kari Laine, Kari Leino, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypesMikko Niemi, Ingolf Cascorbi, Ramona Timm, et al.
European Journal of Clinical Pharmacology|June 8, 2006
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamideMikko Niemi, Aleksi Tornio, Marja K Pasanen, et al.
Pageof 20